Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar
- PMID: 21451207
Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar
Abstract
The aim of the study was to define the effect of pharmacological doses of melatonin, an agent known to be a scavenger of reactive oxygen species, on the extracellular matrix composition (glycosaminoglycans and collagen) in the infarcted heart scar. Rats were administered with melatonin at doses of 300 μg/100 g b.w. or 3 mg/100 g b.w. once daily (between 5:00 and 6:00 in the afternoon) or with 1.5 mg/100 g b.w. twice daily (between 8:00 and 9:00 in the morning and additionally between 5:00 and 6:00 in the afternoon). The levels of collagen, glycosaminoglycans (GAG) and some oxidative stress markers (lipid oxidation, the content of sulphydryl groups in proteins and glutathione) were evaluated. In the second part of the experiment, cells were isolated from the scar, identified as myofibroblasts, cultured and treated with melatonin at concentrations ranging from 10⁻⁷ M to 10⁻¹⁰ M. The pineal indoleamine was seen to reduce the GAG content of the scar, while the collagen content of the scar remained unchanged. A 10⁻⁷ M concentration of melatonin caused an increase in the GAG level in the myofibroblast cultures, while lower concentrations (10⁻⁸ M-10⁻¹⁰ M) of pineal indoleamine were not effective. Melatonin decreased lipid oxidation and increased the sulphydryl groups of total proteins and glutathione, which suggests its antioxidative activity in the applied doses. The present study shows that pharmacological doses of melatonin reduce the GAG level in an infarcted heart scar. Since the mechanism of GAG content reduction cannot be explained by direct action of the pineal indoleamine on myofibroblasts in the myocardial infarction scar, we hypothesise that changes in GAG content could be indirectly induced by melatonin, that is caused by changes in regulatory systems or reduction of the inflammatory reaction in the area of the infarction. In addition, this paper shows that long-term treatment with melatonin of rats affected by myocardial infarction may reduce oxidative stress in the infarction area.
Similar articles
-
Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar.J Pineal Res. 2008 Oct;45(3):285-90. doi: 10.1111/j.1600-079X.2008.00588.x. Epub 2008 Apr 1. J Pineal Res. 2008. PMID: 18384532
-
Melatonin augments expression of the procollagen α1 (I) and α1 (III) genes in the infarcted heart scar of pinealectomized rats.Connect Tissue Res. 2010 Dec;51(6):491-6. doi: 10.3109/03008201003686966. Epub 2010 Apr 13. Connect Tissue Res. 2010. PMID: 20388018
-
Melatonin-induced glycosaminoglycans augmentation in myocardium remote to infarction.J Physiol Pharmacol. 2013 Dec;64(6):737-44. J Physiol Pharmacol. 2013. PMID: 24388888
-
Melatonin-induced augmentation of collagen deposition in cultures of fibroblasts and myofibroblasts is blocked by luzindole--a melatonin membrane receptors inhibitor.Pharmacol Rep. 2013;65(3):642-9. doi: 10.1016/s1734-1140(13)71041-7. Pharmacol Rep. 2013. PMID: 23950586
-
Physiological Implications of Myocardial Scar Structure.Compr Physiol. 2015 Sep 20;5(4):1877-909. doi: 10.1002/cphy.c140067. Compr Physiol. 2015. PMID: 26426470 Free PMC article. Review.
Cited by
-
Melatonin and the cardiovascular system in animals: systematic review and meta-analysis.Clinics (Sao Paulo). 2021 Oct 11;76:e2863. doi: 10.6061/clinics/2021/e2863. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 34644731 Free PMC article.
-
Melatonin increases collagen content accumulation and Fibroblast Growth Factor-2 secretion in cultured human cardiac fibroblasts.Pharmacol Rep. 2023 Jun;75(3):560-569. doi: 10.1007/s43440-023-00490-4. Epub 2023 May 15. Pharmacol Rep. 2023. PMID: 37188903 Free PMC article.
-
Melatonin in Heart Failure: A Promising Therapeutic Strategy?Molecules. 2018 Jul 22;23(7):1819. doi: 10.3390/molecules23071819. Molecules. 2018. PMID: 30037127 Free PMC article. Review.
-
The potential therapeutic role of melatonin in organ fibrosis: a comprehensive review.Front Med (Lausanne). 2024 Dec 13;11:1502368. doi: 10.3389/fmed.2024.1502368. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39735699 Free PMC article. Review.
-
Melatonin as a protective agent in cardiac ischemia-reperfusion injury: Vision/Illusion?Eur J Pharmacol. 2020 Oct 15;885:173506. doi: 10.1016/j.ejphar.2020.173506. Epub 2020 Aug 26. Eur J Pharmacol. 2020. PMID: 32858050 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical